Watchlist Price Alert

Sage Therapeutics Inc. (SAGE)

NASDAQ: SAGE · Real-Time Price · USD

9.10

0.03 (0.33%)

At close: Jun 17, 2025, 1:49 PM

Sage Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	81.02M	70.99M	162.7M	294.23M	1.66B	126.7M	190.94M	306.24M	168.52M
Short-Term Investments	423.4M	682.19M	1.11B	1.45B	438.47M	881.69M	731.83M	212.61M	228.96M
Long-Term Investments	n/a	n/a	1.27M	1.27M	1.72M	2.37M	2.37M	849K	564K
Other Long-Term Assets	4.28M	6.55M	69.26M	4.25M	3.34M	3.79M	-2.37M	-849K	-564K
Receivables	9.13M	83.01M	13.66M	18.51M	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	-64.49M	-18.51M	n/a	n/a	n/a	n/a	n/a
Other Current Assets	17.75M	33.16M	50.83M	n/a	22.82M	26.7M	21.92M	6.23M	5.1M
Total Current Assets	531.3M	869.35M	1.27B	1.8B	2.12B	1.04B	944.7M	525.08M	402.58M
Property-Plant & Equipment	11.64M	6.38M	13.43M	19.13M	31.82M	42.9M	8.01M	4.86M	1.95M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	15.92M	12.93M	83.95M	24.64M	36.88M	49.06M	8.01M	4.86M	1.95M
Total Assets	547.22M	882.28M	1.36B	1.83B	2.16B	1.08B	952.71M	529.94M	404.53M
Account Payables	12.7M	10.32M	18.95M	10.45M	3.69M	15.27M	34.04M	9.35M	12.82M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	7.64M	7.47M	8.66M	10.24M	n/a	n/a	n/a
Other Current Liabilities	14.84M	21.34M	35.65M	41.19M	31.62M	54.36M	32.36M	26.76M	16.4M
Total Current Liabilities	71.61M	82.75M	99.26M	85.19M	67.2M	112.13M	86.03M	51.95M	35.17M
Long-Term Debt	n/a	n/a	4.49M	10.96M	19.44M	26.85M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-4.39M	-10.86M	-19.17M	-26.33M	3.7M	2.51M	845K
Total Long-Term Liabilities	10.52M	n/a	4.59M	11.06M	19.71M	27.37M	3.7M	2.51M	845K
Total Liabilities	82.13M	82.75M	103.85M	96.26M	86.91M	139.5M	89.73M	54.46M	36.01M
Total Debt	11.84M	5.17M	12.13M	18.43M	28.1M	37.09M	n/a	n/a	n/a
Common Stock	6K	6K	6K	6K	6K	5K	5K	5K	4K
Retained Earnings	-2.97B	-2.57B	-2.03B	-1.5B	-1.04B	-1.64B	-963.33M	-590.45M	-320.33M
Comprehensive Income	244K	-814K	-10.21M	-2.66M	415K	1.29M	-515K	-29K	-102K
Shareholders Equity	465.09M	799.53M	1.25B	1.73B	2.07B	944.65M	862.97M	475.48M	368.52M
Total Investments	423.4M	682.19M	1.11B	1.45B	438.47M	881.69M	731.83M	212.61M	228.96M